A Composite Assay for HER2-positive Early-stage Breast Cancer Management

Clinical trial NCT06762977 · RECRUITING

Trial details

NCT number: NCT06762977
Sponsor: Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Status: RECRUITING
Study type: OBSERVATIONAL

Breast Cancer Early Stage Breast Cancer (Stage 1-3)HER2

Start date: 2024-11-13
Primary completion: 2025-08-01
Enrollment: 180

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.